US 12,347,548 B2
Medication enhancement systems and methods for cognitive benefit
Grigore C. Burdea, Highland Park, NJ (US); and Edward A. Berde, Princeton, NJ (US)
Assigned to Bright Cloud International Corporation
Filed by Bright Cloud International Corporation, Highland Park, NJ (US)
Filed on Mar. 13, 2020, as Appl. No. 16/818,964.
Claims priority of provisional application 62/817,962, filed on Mar. 13, 2019.
Prior Publication US 2020/0294652 A1, Sep. 17, 2020
Int. Cl. G16H 20/70 (2018.01); A61B 5/00 (2006.01); A61B 5/16 (2006.01); A63F 13/213 (2014.01); G09B 5/02 (2006.01); G09B 19/00 (2006.01); G16H 20/10 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01)
CPC G16H 20/70 (2018.01) [A61B 5/0022 (2013.01); A61B 5/163 (2017.08); A61B 5/165 (2013.01); A61B 5/4088 (2013.01); A61B 5/4848 (2013.01); A61B 5/6803 (2013.01); A63F 13/213 (2014.09); G09B 5/02 (2013.01); G09B 19/00 (2013.01); G16H 20/10 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01)] 11 Claims
OG exemplary drawing
 
1. A method for providing cognitive therapy to a patient, comprising the steps of:
providing a head mounted device wearable by a patient, a testing display configured to present one or more cognitive training scenes to the patient, one or more controllers enabling the patient to interact with the one or more cognitive training scenes, a cognitive engagement detection device configured to detect cognitive engagement of the patient, and one or more processors in communication with the head mounted device, the testing display, the one or more controllers, and the cognitive engagement detection device, the cognitive engagement detection device comprising one or more sensors;
providing, by the one or more processors, a cognitive medication dosage for a patient on a patient information display device;
generating, by the one or more processors, one or more cognitive training scenes and displaying the one or more cognitive training scenes on the testing display;
receiving data indicative of the cognitive state of the patient from a memory of the cognitive engagement detection device based on input provided by at least one of the one or more sensors, the data indicative of the cognitive state comprising data indicative of cognitive engagement and data indicative of cognitive fatigue, the cognitive engagement being a mental effort of the patient learning to interact with the one or more cognitive training scenes and success in performing gaming tasks related to the one or more cognitive training scenes, the cognitive fatigue being an impaired sensory and attention-related mental processing of the patient;
receiving information from the one or more controllers;
determining the cognitive engagement and cognitive fatigue of the patient based at least in part on the data received from the cognitive engagement detection device;
determining performance of the patient interacting with the one or more cognitive training scenes based on the information received from the one or more controllers;
determining, via the one or more processors, a modification of the cognitive medication dosage or cognitive medication type based on the cognitive engagement, cognitive fatigue, a type of the patient, and the performance of the patient; and
displaying the modification of the cognitive medication dosage or cognitive medication type on the patient information display device.